← FDA DRUG APPROVALS

FDA ANDA · ANDA040013

LIDOCAINE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA040013
TYPE
ANDA
ORIGINAL APPROVAL
1995-06-23
LATEST ACTION
2002-01-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

2002-01-02Labeling · Supplement 4AP
2001-02-14Manufacturing (CMC) · Supplement 3AP
1996-05-07Manufacturing (CMC) · Supplement 2AP
1996-04-23Manufacturing (CMC) · Supplement 1AP
1995-06-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →